Intestine-Specific Mttp Deletion Decreases Mortality and Prevents Sepsis-Induced Intestinal Injury in a Murine Model of Pseudomonas aeruginosa Pneumonia

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Dominguez, Jessica A ^a,d   Xie, Yan ^a   Dunne, W Michael ^a   Yoseph, Benyam P ^b   Burd, Eileen M ^c   Coopersmith, Craig M ^b   Davidson, Nicholas O ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; CHYLOMICRON; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 6; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL LOAD; CELL PROLIFERATION; CONTROLLED STUDY; CRYPT DEPTH; DIGESTIVE TRACT PARAMETERS; EXPERIMENTAL MODEL; INTESTINE INJURY; LIPID TRANSPORT; LIPOPROTEIN BLOOD LEVEL; MALABSORPTION; MORTALITY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN SECRETION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PNEUMONIA; SEPSIS; SURVIVAL; VILLUS LENGTH;

ANIMALS; APOPTOSIS; CARRIER PROTEINS; CHYLOMICRON REMNANTS; DISEASE MODELS, ANIMAL; FEMALE; GENE DELETION; HUMANS; INTESTINAL DISEASES; INTESTINES; MALE; MICE; PNEUMONIA; PSEUDOMONAS AERUGINOSA; SEPSIS;

BACTERIA (MICROORGANISMS); MURINAE; MUS; PSEUDOMONAS AERUGINOSA;

EID: 84869051728     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049159     Document Type: Article

References (52)

1. Heron M, Hoyert DL, Murphy SL, Xu J, Kochanek KD, et al. (2009) Deaths: final data for 2006. Natl Vital Stat Rep 57: 1-134.
2. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20: 864-874.
3. Wenzel RP, Edmond MB, (2012) Septic shock-evaluating another failed treatment. N Engl J Med 366: 2122-2124.
4. Clark JA, Coopersmith CM, (2007) Intestinal crosstalk: a new paradigm for understanding the gut as the "motor" of critical illness. Shock 28: 384-393.
5. Hassoun HT, Kone BC, Mercer DW, Moody FG, Weisbrodt NW, et al. (2001) Post-injury multiple organ failure: the role of the gut. Shock 15: 1-10.
6. Deitch EA, Xu D, Kaise VL, (2006) Role of the gut in the development of injury- and shock induced SIRS and MODS: the gut-lymph hypothesis, a review. Front Biosci 11: 520-528.
7. Deitch EA, (2010) Gut lymph and lymphatics: a source of factors leading to organ injury and dysfunction. Ann N Y Acad Sci 1207Suppl 1: E103-111.
8. Deitch EA, Forsythe R, Anjaria D, Livingston DH, Lu Q, et al. (2004) The role of lymph factors in lung injury, bone marrow suppression, and endothelial cell dysfunction in a primate model of trauma-hemorrhagic shock. Shock 22: 221-228.
9. Senthil M, Brown M, Xu DZ, Lu Q, Feketeova E, et al. (2006) Gut-lymph hypothesis of systemic inflammatory response syndrome/multiple-organ dysfunction syndrome: validating studies in a porcine model. J Trauma 60: 958-965; discussion 965-957.
10. Strandberg L, Verdrengh M, Enge M, Andersson N, Amu S, et al. (2009) Mice chronically fed high-fat diet have increased mortality and disturbed immune response in sepsis. PLoS One 4: e7605.
11. Kaplan JM, Nowell M, Lahni P, O'Connor MP, Hake PW, et al. (2012) Short-Term High Fat Feeding Increases Organ Injury and Mortality After Polymicrobial Sepsis. Obesity (Silver Spring).
12. Hiramatsu M, Hotchkiss RS, Karl IE, Buchman TG, (1997) Cecal ligation and puncture (CLP) induces apoptosis in thymus, spleen, lung, and gut by an endotoxin and TNF-independent pathway. Shock 7: 247-253.
13. Hotchkiss RS, Swanson PE, Freeman BD, Tinsley KW, Cobb JP, et al. (1999) Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 27: 1230-1251.
14. Coopersmith CM, Chang KC, Swanson PE, Tinsley KW, Stromberg PE, et al. (2002) Overexpression of Bcl-2 in the intestinal epithelium improves survival in septic mice. Crit Care Med 30: 195-201.
15. Coopersmith CM, Stromberg PE, Dunne WM, Davis CG, Amiot DM 2nd, et al (2002) Inhibition of intestinal epithelial apoptosis and survival in a murine model of pneumonia-induced sepsis. JAMA 287: 1716-1721.
16. Coopersmith CM, Stromberg PE, Davis CG, Dunne WM, Amiot DM 2nd, et al (2003) Sepsis from Pseudomonas aeruginosa pneumonia decreases intestinal proliferation and induces gut epithelial cell cycle arrest. Crit Care Med 31: 1630-1637.
17. Dominguez JA, Vithayathil PJ, Khailova L, Lawrance CP, Samocha AJ, et al. (2011) Epidermal growth factor improves survival and prevents intestinal injury in a murine model of pseudomonas aeruginosa pneumonia. Shock 36: 381-389.
18. Mainous MR, Ertel W, Chaudry IH, Deitch EA, (1995) The gut: a cytokine-generating organ in systemic inflammation? Shock 4: 193-199.
19. Clark JA, Gan H, Samocha AJ, Fox AC, Buchman TG, et al. (2009) Enterocyte-specific epidermal growth factor prevents barrier dysfunction and improves mortality in murine peritonitis. Am J Physiol Gastrointest Liver Physiol 297: G471-479.
20. De-Souza DA, Greene LJ, (2005) Intestinal permeability and systemic infections in critically ill patients: effect of glutamine. Crit Care Med 33: 1125-1135.
21. Neal MD, Leaphart C, Levy R, Prince J, Billiar TR, et al. (2006) Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier. J Immunol 176: 3070-3079.
22. Xie Y, Newberry EP, Young SG, Robine S, Hamilton RL, et al. (2006) Compensatory increase in hepatic lipogenesis in mice with conditional intestine-specific Mttp deficiency. J Biol Chem 281: 4075-4086.
23. Berriot-Varoqueaux N, Aggerbeck LP, Samson-Bouma M, Wetterau JR, (2000) The role of the microsomal triglygeride transfer protein in abetalipoproteinemia. Annu Rev Nutr 20: 663-697.
24. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, et al. (2008) NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 29: 996-1011.
25. McConnell KW, McDunn JE, Clark AT, Dunne WM, Dixon DJ, et al. (2010) Streptococcus pneumoniae and Pseudomonas aeruginosa pneumonia induce distinct host responses. Crit Care Med 38: 223-241.
26. Abd H, Wretlind B, Saeed A, Idsund E, Hultenby K, et al. (2008) Pseudomonas aeruginosa utilises its type III secretion system to kill the free-living amoeba Acanthamoeba castellanii. J Eukaryot Microbiol 55: 235-243.
27. Vyas D, Robertson CM, Stromberg PE, Martin JR, Dunne WM, et al. (2007) Epithelial apoptosis in mechanistically distinct methods of injury in the murine small intestine. Histol Histopathol 22: 623-630.
28. Xie Y, Kennedy S, Sidhu R, Luo J, Ory DS, et al. (2012) Liver X receptor agonist modulation of cholesterol efflux in mice with intestine-specific deletion of microsomal triglyceride transfer protein. Arterioscler Thromb Vasc Biol 32: 1624-1631.
29. Bilbault P, Lavaux T, Launoy A, Gaub MP, Meyer N, et al. (2007) Influence of drotrecogin alpha (activated) infusion on the variation of Bax/Bcl-2 and Bax/Bcl-xl ratios in circulating mononuclear cells: a cohort study in septic shock patients. Crit Care Med 35: 69-75.
30. Stromberg PE, Woolsey CA, Clark AT, Clark JA, Turnbull IR, et al. (2009) CD4+ lymphocytes control gut epithelial apoptosis and mediate survival in sepsis. FASEB J 23: 1817-1825.
31. Ghoshal S, Witta J, Zhong J, de Villiers W, Eckhardt E, (2009) Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res 50: 90-97.
32. Ganeshan K, Bryce PJ, (2012) Regulatory T cells enhance mast cell production of IL-6 via surface-bound TGF-beta. J Immunol 188: 594-603.
33. Brunham LR, Kruit JK, Iqbal J, Fievet C, Timmins JM, et al. (2006) Intestinal ABCA1 directly contributes to HDL biogenesis in vivo. J Clin Invest 116: 1052-1062.
34. Brunham LR, Kruit JK, Pape TD, Parks JS, Kuipers F, et al. (2006) Tissue-specific induction of intestinal ABCA1 expression with a liver X receptor agonist raises plasma HDL cholesterol levels. Circ Res 99: 672-674.
35. McGillicuddy FC, de la Llera Moya M, Hinkle CC, Joshi MR, Chiquoine EH, et al. (2009) Inflammation impairs reverse cholesterol transport in vivo. Circulation 119: 1135-1145.
36. Ott J, Hiesgen C, Mayer K, (2011) Lipids in critical care medicine. Prostaglandins Leukot Essent Fatty Acids 85: 267-273.
37. Wu A, Hinds CJ, Thiemermann C, (2004) High-density lipoproteins in sepsis and septic shock: metabolism, actions, and therapeutic applications. Shock 21: 210-221.
38. Lanza-Jacoby S, Miller S, Jacob S, Heumann D, Minchenko AG, et al. (2003) Hyperlipoproteinemic low-density lipoprotein receptor-deficient mice are more susceptible to sepsis than corresponding wild-type mice. J Endotoxin Res 9: 341-347.
39. van Leeuwen HJ, Heezius EC, Dallinga GM, van Strijp JA, Verhoef J, et al. (2003) Lipoprotein metabolism in patients with severe sepsis. Crit Care Med 31: 1359-1366.
40. Barcia AM, Harris HW, (2005) Triglyceride-rich lipoproteins as agents of innate immunity. Clin Infect Dis 41Suppl 7: S498-503.
41. Kasravi B, Lee DH, Lee JW, Dada S, Harris HW, (2008) Chylomicron-bound LPS selectively inhibits the hepatocellular response to proinflammatory cytokines. J Surg Res 146: 96-103.
42. Grivennikov S, Karin E, Terzic J, Mucida D, Yu GY, et al. (2009) IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15: 103-113.
43. Zhang Z, Datta G, Zhang Y, Miller AP, Mochon P, et al. (2009) Apolipoprotein A-I mimetic peptide treatment inhibits inflammatory responses and improves survival in septic rats. Am J Physiol Heart Circ Physiol 297: H866-873.
44. Suzuki M, Pritchard DK, Becker L, Hoofnagle AN, Tanimura N, et al. (2010) High-density lipoprotein suppresses the type I interferon response, a family of potent antiviral immunoregulators, in macrophages challenged with lipopolysaccharide. Circulation 122: 1919-1927.
45. Gonzalez RJ, Moore EE, Biffl WL, Ciesla DJ, Silliman CC, (2000) The lipid fraction of post-hemorrhagic shock mesenteric lymph (PHSML) inhibits neutrophil apoptosis and enhances cytotoxic potential. Shock 14: 404-408.
46. Wang Y, Li J, Tang L, Wang Y, Charnigo R, et al. (2010) T-lymphocyte responses to intestinally absorbed antigens can contribute to adipose tissue inflammation and glucose intolerance during high fat feeding. PLoS One 5: e13951.
47. Mancuso P, Huffnagle GB, Olszewski MA, Phipps J, Peters-Golden M, (2006) Leptin corrects host defense defects after acute starvation in murine pneumococcal pneumonia. Am J Respir Crit Care Med 173: 212-218.
48. Mancuso P, Gottschalk A, Phare SM, Peters-Golden M, Lukacs NW, et al. (2002) Leptin-deficient mice exhibit impaired host defense in Gram-negative pneumonia. J Immunol 168: 4018-4024.
49. Fox AC, Robertson CM, Belt B, Clark AT, Chang KC, et al. (2010) Cancer causes increased mortality and is associated with altered apoptosis in murine sepsis. Crit Care Med 38: 886-893.
50. Raabe M, Veniant MM, Sullivan MA, Zlot CH, Bjorkegren J, et al. (1999) Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice. J Clin Invest 103: 1287-1298.
51. Cuchel M, Bloedon LT, Szapary PO, Kolansky DM, Wolfe ML, et al. (2007) Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia. N Engl J Med 356: 148-156.
52. Kim E, Campbell S, Schueller O, Wong E, Cole B, et al. (2011) A small-molecule inhibitor of enterocytic microsomal triglyceride transfer protein, SLx-4090: biochemical, pharmacodynamic, pharmacokinetic, and safety profile. J Pharmacol Exp Ther 337: 775-785.